[1]
V. P. Frade, “Phenobarbital: effect of interchangeability on the profile of adverse effect, on quality of life and on plasma concentrations - a pilot study”, J Hosp Pharm Health Serv, vol. 10, no. 1, p. 410, Mar. 2019.